← Back to Holdings
Sofinnova Investments, Inc.
CIK 1631134 · 2024-Q4 · 2 filing(s) · prev: 2024-Q3
Total Portfolio Value
$1.4T
Positions
61
17 exited vs prev quarter
Latest Filing
2024-Q4
Due Diligence Score
Institutional quality assessment based on 13F data
F
30 / 100
Filing Longevity3/30
2 quarters of history
Portfolio Breadth2/25
60 positions
Equity Purity20/20
1 options positions (1.6%)
Concentration Balance5/25
Top-5 = 40.9% of portfolio
Loading timeline…
AI Portfolio Analysis
Claude-powered institutional analyst commentary
Portfolio Profile
Relative positioning across key dimensions (0–100)
Top Holdings by Value
Top 30 positions by value
| # | Issuer | Class | CUSIP | Value | Shares | % Portfolio | Type |
|---|---|---|---|---|---|---|---|
| 1 | ▲Natera Inc | COM | 632307104 | $245.4B | 1,550,280 | 17.88% | EQ |
| 2 | ▼Vera Therapeutics Inc | CL A | 92337R101 | $118.2B | 2,793,987 | 8.61% | EQ |
| 3 | NEWGilead Sciences Inc | COM | 375558103 | $71.5B | 774,227 | 5.21% | EQ |
| 4 | NEWAbbVie Inc | COM | 00287Y109 | $63.9B | 359,393 | 4.65% | EQ |
| 5 | ▲Jazz Pharmaceuticals PLC | SHS USD | G50871105 | $62.1B | 504,193 | 4.52% | EQ |
| 6 | NEWSarepta Therapeutics Inc | COM | 803607100 | $52.1B | 428,771 | 3.80% | EQ |
| 7 | ▲Arrivent BioPharma Inc | COM | 04272N102 | $45.2B | 1,696,752 | 3.29% | EQ |
| 8 | ▼AstraZeneca PLC | SPONSORED ADR | 046353108 | $42.7B | 651,344 | 3.11% | EQ |
| 9 | NEWStryker Corporation | COM | 863667101 | $41.8B | 116,005 | 3.04% | EQ |
| 10 | ▲Axsome Therapeutics Inc | COM | 05464T104 | $41.6B | 491,726 | 3.03% | EQ |
| 11 | ▲Replimune Group Inc | COM | 76029N106 | $38.1B | 3,149,522 | 2.78% | EQ |
| 12 | ▼Incyte Corp | COM | 45337C102 | $36.2B | 524,267 | 2.64% | EQ |
| 13 | ▲Rapport Therapeutics Inc | COM | 75383L102 | $35.4B | 1,995,594 | 2.58% | EQ |
| 14 | ▲Soleno Therapeutics Inc | COM | 834203309 | $34.0B | 757,248 | 2.48% | EQ |
| 15 | ▲Boston Scientific Corp | COM | 101137107 | $31.0B | 346,571 | 2.25% | EQ |
| 16 | ▼IDEAYA Biosciences Inc | COM | 45166A102 | $27.5B | 1,069,090 | 2.00% | EQ |
| 17 | NEWAlnylam Pharmaceuticals Inc | COM | 02043Q107 | $25.9B | 110,157 | 1.89% | EQ |
| 18 | NEWAlkermes Plc | SHS | G01767105 | $25.7B | 894,266 | 1.87% | EQ |
| 19 | ▼Dyne Therapeutics Inc | COM | 26818M108 | $25.2B | 1,071,498 | 1.84% | EQ |
| 20 | NEWDexcom Inc | COM | 252131107 | $22.6B | 290,210 | 1.64% | EQ |
| 21 | ▲Rhythm Pharmaceuticals Inc | COM | 76243J105 | $22.2B | 397,428 | 1.62% | EQ |
| 22 | NEWGlobus Med Inc | CL A | 379577208 | $20.2B | 244,700 | 1.47% | EQ |
| 23 | NEWIntuitive Surgical Inc | COM | 46120E602 | $19.8B | 37,896 | 1.44% | EQ |
| 24 | ▼Insmed Inc | COM PAR $.01 | 457669307 | $17.7B | 256,281 | 1.29% | EQ |
| 25 | ▼Y-mAbs Therapeutics Inc | COM | 984241109 | $17.2B | 2,194,278 | 1.25% | EQ |
| 26 | ▼Savara Inc | COM | 805111101 | $16.8B | 5,471,299 | 1.22% | EQ |
| 27 | ▲Janux Therapeutics Inc | COM | 47103J105 | $13.6B | 253,262 | 0.99% | EQ |
| 28 | ▲BioAge Labs Inc | COM | 09077V100 | $13.3B | 2,304,901 | 0.97% | EQ |
| 29 | ▼Inozyme Pharma Inc | COM | 45790W108 | $11.9B | 4,280,308 | 0.86% | EQ |
| 30 | NEWEli Lilly & Co | COM | 532457108 | $11.1B | 14,364 | 0.81% | EQ |
| 31 | ▲Edgewise Therapeutics Inc | COM | 28036F105 | $10.8B | 402,773 | 0.78% | EQ |
| 32 | ▼Pharvaris N V | COM | N69605108 | $10.7B | 560,723 | 0.78% | EQ |
| 33 | ▲Aerovate Therapeutics Inc | COM | 008064107 | $10.0B | 3,758,686 | 0.73% | EQ |
| 34 | ▲Inari Med Inc | COM | 45332Y109 | $9.2B | 180,456 | 0.67% | EQ |
| 35 | ▼Syndax Pharmaceuticals Inc | COM | 87164F105 | $8.7B | 658,627 | 0.63% | EQ |
| 36 | NEWAxsome Therapeutics Inc | COM | 05464T104 | $8.5B | 100,000 | 0.62% | Call |
| 37 | ▼Inhibrx Biosciences Inc | COM | 45720N103 | $8.1B | 527,190 | 0.59% | EQ |
| 38 | ▼Immunome Inc | COM | 45257U108 | $7.9B | 746,824 | 0.58% | EQ |
| 39 | ▼Cogent Biosciences Inc | COM | 19240Q201 | $6.4B | 823,160 | 0.47% | EQ |
| 40 | ▼Achieve Life Sciences Inc | COM | 004468500 | $4.6B | 1,306,482 | 0.33% | EQ |
| 41 | ▼Erasca Inc | COM | 29479A108 | $4.5B | 1,795,880 | 0.33% | EQ |
| 42 | ▼Establishment Labs Hldgs Inc | COM | G31249108 | $4.4B | 95,305 | 0.32% | EQ |
| 43 | NEWAvantor Inc | COM | 05352A100 | $4.2B | 200,000 | 0.31% | EQ |
| 44 | ▼Edwards Lifesciences Corp | COM | 28176E108 | $3.0B | 40,000 | 0.22% | EQ |
| 45 | ▲Exact Sciences Corp | COM | 30063P105 | $2.9B | 52,042 | 0.21% | EQ |
| 46 | ▼Immatics N.V | SHS | N44445109 | $2.4B | 343,206 | 0.18% | EQ |
| 47 | NEWDanaher Corporation | COM | 235851102 | $2.3B | 10,000 | 0.17% | EQ |
| 48 | ▼Nextcure Inc | COM | 65343E108 | $2.1B | 2,671,856 | 0.15% | EQ |
| 49 | NEWAnaptysBio Inc | COM | 032724106 | $1.8B | 132,927 | 0.13% | EQ |
| 50 | NEWKeros Therapeutics Inc | COM | 492327101 | $1.5B | 95,375 | 0.11% | EQ |
| 51 | ▼Bolt Biotherapeutics Inc | COM | 097702104 | $1.5B | 2,754,437 | 0.11% | EQ |
| 52 | ▼Disc Medicine Inc | COM | 254604101 | $1.4B | 22,752 | 0.11% | EQ |
| 53 | ▼Becton Dickinson & Co | COM | 075887109 | $1.1B | 4,951 | 0.08% | EQ |
| 54 | ▼Vir Biotechnology Inc | COM | 92764N102 | $837.7M | 114,131 | 0.06% | EQ |
| 55 | NEWICU Med Inc | COM | 44930G107 | $775.9M | 5,000 | 0.06% | EQ |
| 56 | NEWEnliven Therapeutics Inc | COM | 29337E102 | $765.6M | 34,025 | 0.06% | EQ |
| 57 | ▼Ikena Oncology Inc | COM | 45175G108 | $627.5M | 382,616 | 0.05% | EQ |
| 58 | NEWTravere Therapeutics Inc | COM | 89422G107 | $568.2M | 32,616 | 0.04% | EQ |
| 59 | ▼Structure Therapeutics Inc | SPONSORED ADS | 86366E106 | $566.6M | 20,892 | 0.04% | EQ |
| 60 | ▼Pulmonx Corp | COM | 745848101 | $416.4M | 61,326 | 0.03% | EQ |
| 61 | ▼Avidity Biosciences Inc | COM | 05370A108 | $401.0M | 13,789 | 0.03% | EQ |